BioSpace News Archive

Business

KemPharm Presents Study Highlighting Patient-Friendly Dosing Properties of KP415 at the 66th Annual American Academy of Child & Adolescent Psychiatry Meeting

Data Demonstrate that KP415 Can Be Administered without Regard to Food; Can Be Mixed into Foods or Drink

October 22, 2019
·
4 min read
Business

Veracyte Announces Third Quarter 2019 Financial Results and Business Progress

Veracyte, Inc. announced financial results and business progress for the third quarter ended September 30, 2019.

October 22, 2019
·
7 min read
Genetown

Moderna Receives FDA Fast Track Designation for Propionic Acidemia Program (mRNA-3927)

mRNA-3927 is Moderna’s second rare disease program to receive Fast Track designation

October 22, 2019
·
7 min read
Policy

Don’t let injuries be the scariest part of Halloween

Halloween is upon us! Pumpkin patches, haunted houses and trick-or-treating are fun and festive ways to celebrate this holiday, but the excitement of these activities can quickly turn dangerous if you’re not careful.

October 22, 2019
·
3 min read
Deals

Discovery Behavioral Health Acquires New Life Addiction Counseling & Mental Health Services

Baltimore Area Center Offers Evidence-Based, Outpatient Treatment of Adult Drug and Alcohol Addiction and Co-Occurring Mental Health Issues

October 22, 2019
·
2 min read
Deals

Medicom Acquires Hedy Canada

Acquisition by global infection control leader solidifies segment leadership in Canada

October 22, 2019
·
2 min read
Business

Glaukos Corporation to Release Third Quarter 2019 Financial Results after Market Close on November 6

Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, plans to release third quarter 2019 financial results after the market close on Wednesday, November 6, 2019.

October 22, 2019
·
1 min read
Drug Development

MacroGenics Announces Second Interim Overall Survival Data from Phase 3 SOPHIA Study of Margetuximab in Patients with HER2-Positive Metastatic Breast Cancer

MacroGenics, Inc. announced topline results from the second pre-specified interim overall survival analysis for the Phase 3 SOPHIA study of margetuximab in patients with HER2-positive metastatic breast cancer who have previously been treated with anti-HER2-targeted therapies.

October 22, 2019
·
8 min read
Deals

STERIS to Host a Conference Call for Fiscal 2020 Second Quarter Financial Results on November 5, 2019

STERIS plc announced that it will host a conference call to discuss its fiscal 2020 second quarter financial results at 10:00 a.m. Eastern Time on Tuesday, November 5, 2019.

October 22, 2019
·
6 min read
Pharm Country

Beyond Air™ to Attend the American Academy of Pediatrics (AAP) National Conference and Exhibition in New OrleansCompany will showcase LungFit™ technology at Booth #1330

Beyond Air, Inc. announced it would be attending the 2019 American Academy of Pediatrics Annual National Conference and Exhibition being held October 25 – 29, 2019 in New Orleans.

October 22, 2019
·
4 min read